The chemotherapy docetaxel is widely accepted as a standard therapy for metastatic castration-resistant prostate cancer. But 10-20 percent of patients will have adverse side effects that force discontinuation of treatment. These patients may have been ...and more »
PA Earned Mixed Scores In Cancer Treatment Study
HARRISBURG (WSKG) - A study released by the American Cancer Society has given Pennsylvania mixed reviews for its work to prevent and treat cancer. The state earned particularly low marks on funding anti-tobacco programs--an issue that has lately ...
No comments:
Post a Comment